Screener › Most Undervalued by Analyst Price Targets
Most Undervalued by Analyst Price Targets
Stocks with the highest upside potential to analyst consensus price targets — filtered for quality businesses with meaningful analyst coverage.
| Ticker | Company | Price | Target upside | Target mean | Pe ratio | Num analysts |
|---|---|---|---|---|---|---|
| CRBU | Caribou Biosciences | $2.10 +5.53% | 471.4% | $12.00 | — | 7 |
| NNOX | Nano-X Imaging | $1.84 -3.66% | 291.3% | $7.20 | — | 3 |
| CCCC | C4 Therapeutics | $3.56 +1.14% | 225% | $11.57 | — | 7 |
| OCUL | Ocular Therapeutix | $8.23 +0.12% | 215.9% | $26.00 | — | 11 |
| VKTX | Viking Therapeutics | $30.89 +0.68% | 198.9% | $92.33 | — | 18 |
| OPK | OPKO Health | $1.27 -0.78% | 196.1% | $3.76 | — | 5 |
| BLNK | Blink Charging | $0.82 -1.18% | 174.3% | $2.25 | — | 4 |
| HYQ.DE | Hypoport | $79.00 -3.25% | 169.3% | €212.75 | 18.7x | 4 |
| ARDX | Ardelyx | $6.11 -3.78% | 167.3% | $16.33 | — | 9 |
| CRVS | Corvus Pharmaceuticals | $12.61 -3.59% | 164.3% | $33.33 | — | 6 |
| EU | enCore Energy | $1.48 +0.68% | 157.3% | $3.81 | — | 4 |
| TELA | Tela Bio | $0.89 -3.51% | 152.8% | $2.25 | — | 5 |
| XNCR | Xencor | $11.31 +0.35% | 152% | $28.50 | — | 12 |
| FUTU | Futu Holdings | $89.76 -27.53% | 145.1% | $220.03 | 8.8x | 19 |
| EOLS | Evolent Health | $6.09 -5.58% | 140.8% | $14.67 | — | 6 |
| FATE | Fate Therapeutics | $2.25 +7.14% | 140.5% | $5.41 | — | 9 |
| MSTR | MicroStrategy | $159.89 -3.01% | 138.2% | $380.79 | — | 14 |
| RCAT | Red Cat Holdings | $9.41 +4.21% | 131.1% | $21.75 | — | 4 |
| NKTR | Nektar Therapeutics | $66.61 -2.87% | 130.1% | $153.25 | — | 8 |
| SPWH | Sportsmans Warehouse | $1.29 +0% | 126.1% | $2.92 | — | 3 |
| EVGO | EVgo | $1.88 +0% | 126.1% | $4.25 | — | 8 |
| RRGB | Red Robin Gourmet Burgers | $4.56 -2.15% | 122% | $10.12 | — | 4 |
| TTGT | TechTarget | $4.82 +5.01% | 121.3% | $10.67 | — | 3 |
| MNKD | MannKind Corporation | $3.38 +2.11% | 121% | $7.47 | — | 8 |
| RXRX | Recursion Pharmaceuticals | $3.01 -3.22% | 120.7% | $6.64 | — | 7 |
| TTK.DE | Takkt | $2.48 -8.49% | 119.1% | €5.43 | — | 3 |
| IOVA | Iovance Biotherapeutics | $4.11 +11.08% | 114.1% | $8.80 | — | 10 |
| EVEX | Eve Holding | $3.05 +3.74% | 111% | $6.44 | — | 7 |
| ATEC | Alphatec Holdings | $8.27 +0.49% | 109.6% | $17.33 | — | 12 |
| EDIT | Editas Medicine | $2.76 +3.37% | 109.3% | $5.78 | — | 9 |
| TNDM | Tandem Diabetes Care | $14.96 -5.04% | 104% | $30.52 | — | 21 |
| YEXT | Yext | $3.68 +2.51% | 103.8% | $7.50 | 52.6x | 4 |
| ADMA | ADMA Biologics | $8.24 -2.6% | 103.3% | $16.75 | 12.1x | 4 |
| PACB | Pacific Biosciences | $1.22 -2.4% | 101.5% | $2.46 | — | 6 |
| KTOS | Kratos Defense and Security | $56.18 +2.76% | 99.3% | $111.95 | 330.5x | 20 |
| FYB.DE | Formycon | $20.05 +1.98% | 98.8% | €39.86 | — | 7 |
| SKIN | Beauty Health Company | $0.69 +4.21% | 95.1% | $1.34 | — | 6 |
| QFIN | 360 Finance | $11.65 -5.74% | 92.9% | $22.48 | 1.8x | 13 |
| CLDX | Celldex Therapeutics | $30.73 +0.49% | 90.1% | $58.43 | — | 14 |
| PRAX | Praxis Precision Medicine | $343.56 -2% | 89.8% | $652.18 | — | 17 |
| INSM | Insmed | $106.24 -3% | 88.3% | $200.00 | — | 21 |
| CMPS | COMPASS Pathways | $11.81 +1.9% | 88% | $22.20 | — | 15 |
| DNLI | Denali Therapeutics | $18.64 -3.42% | 84.3% | $34.36 | — | 14 |
| ZLAB | Zymeworks | $18.61 -2.57% | 81.5% | $33.78 | — | 12 |
| TRUP | Trupanion | $21.98 +0.59% | 80.9% | $39.75 | 37.3x | 4 |
| DOMO | Domo | $3.63 +1.4% | 79.1% | $6.50 | — | 6 |
| BEAM | Beam Therapeutics | $28.64 +3.51% | 78.3% | $51.07 | — | 15 |
| AVAV | AeroVironment | $174.23 +6.83% | 77.9% | $309.88 | — | 17 |
| NA9.DE | Nagarro | $40.74 +0.84% | 77.3% | €72.25 | 10.8x | 4 |
| WKL.AS | Wolters Kluwer | $62.50 -0.83% | 76.9% | €110.54 | 11.1x | 14 |
| RMNI | Rimini Street | $3.63 +1.11% | 73.6% | $6.30 | 10.1x | 5 |
| BDT.DE | Bertrandt | $10.05 -6.51% | 73.1% | €17.40 | — | 5 |
| SMCP.PA | SMCP | $5.05 +0.5% | 72.5% | €8.72 | 24.1x | 5 |
| SMMT | Summit Therapeutics | $16.62 -4.87% | 71.4% | $28.49 | — | 13 |
| TMDX | TransMedics Group | $68.94 +0.12% | 71% | $117.89 | 15.8x | 9 |
| MGNI | Magnite | $13.20 +0.08% | 68.3% | $22.21 | 12.6x | 14 |
| CPNG | Coupang | $16.12 +2.48% | 68.2% | $27.12 | — | 17 |
| ACHR | Archer Aviation | $6.36 +3.92% | 66.8% | $10.61 | — | 9 |
| ARQT | Arcutis Biotherapeutics | $20.86 -0.71% | 66% | $34.62 | — | 8 |
| SKB.DE | Koenig and Bauer | $9.19 +3.61% | 65.9% | €15.25 | — | 4 |
| MOL.MI | Mutuionline | $31.40 +1.78% | 65.7% | €52.02 | 30.5x | 4 |
| ZEAL.CO | Zealand Pharma | $318.00 +0.98% | 63.2% | $519.07 | 3.6x | 15 |
| WIX | Wix | $53.19 -3.71% | 63.1% | $86.75 | — | 20 |
| ARLO | Arlo Technologies | $13.16 +3.38% | 62.6% | $21.40 | 47x | 5 |
| GSHD | Goosehead Insurance | $41.68 -1.91% | 61.6% | $67.33 | 36.6x | 12 |
| SE | Sea Limited | $87.27 -1.9% | 61.2% | $140.67 | 34.4x | 28 |
| CLBT | Cellebrite DI | $13.18 +0.08% | 60.6% | $21.17 | 47.1x | 6 |
| JACK | Jack in the Box | $11.55 +1.76% | 59.4% | $18.41 | — | 16 |
| STM.DE | Stabilus | $17.76 -1.22% | 59.2% | €28.27 | 29.1x | 7 |
| GLJ.DE | Grenke | $12.62 -1.56% | 58.8% | €20.04 | 9.7x | 5 |
| INVA | Innoviva | $22.46 +1.17% | 58.1% | $35.50 | 3.6x | 4 |
| AGI | Alamos Gold | $38.34 -2.32% | 57.8% | $60.50 | 15.3x | 4 |
| AOF.DE | Atoss Software | $79.80 +1.14% | 57.7% | €125.88 | 26.3x | 8 |
| NRDS | NerdWallet | $8.35 +1.83% | 57.7% | $13.17 | 9x | 6 |
| RYTM | Rhythm Pharmaceuticals | $87.84 -2.61% | 57.3% | $138.20 | — | 15 |
| SDGR | Schrodinger | $13.30 +0.53% | 57% | $20.88 | — | 8 |
| AVPT | AvePoint | $10.29 +0.49% | 56.7% | $16.12 | 51.5x | 13 |
| KELYA | Kelly Services | $10.66 -0.09% | 56.4% | $16.67 | — | 3 |
| RHM.DE | Rheinmetall | $1,227.20 +1.47% | 55.7% | €1,910.81 | 54.9x | 21 |
| IRTC | iRhythm Technologies | $116.56 -1.11% | 55.2% | $180.93 | — | 14 |
| ACVA | ACV Auctions | $5.95 +0.85% | 54.9% | $9.22 | — | 12 |
| TASK | TaskUs | $6.16 +0.65% | 54.2% | $9.50 | 5.5x | 6 |
| ALHC | Alignment Healthcare | $16.35 -0.12% | 53.9% | $25.15 | 163.5x | 13 |
| HDD.DE | Heidelberger Druckmaschinen | $1.35 +0% | 53.6% | €2.08 | 6.1x | 4 |
| NVAX | Novavax | $9.21 +2.56% | 53.2% | $14.11 | — | 9 |
| WEAV | Weave Communications | $5.71 +1.78% | 53.2% | $8.75 | — | 4 |
| SHAK | Shake Shack | $62.72 -0.18% | 53% | $95.96 | 64x | 25 |
| ITRI | Itron | $83.02 +1.43% | 52.6% | $126.70 | 13.3x | 10 |
| BILL | Bill.com Holdings | $36.14 -0.85% | 52.5% | $55.10 | — | 21 |
| VITR.ST | Vitrolife | $106.80 -1.48% | 52.4% | $162.75 | — | 4 |
| USPH | US Physical Therapy | $61.96 -0.69% | 51.2% | $93.67 | 123.9x | 6 |
| OPRA | Opera | $17.43 -0.57% | 50.8% | $26.29 | 13.8x | 7 |
| SBS.DE | Stratec | $17.24 +1.17% | 50.8% | €26.00 | — | 5 |
| HLNE | Hamilton Lane | $90.32 +1.95% | 50.6% | $136.00 | 15.3x | 7 |
| COUR | Coursera | $5.32 +1.53% | 50.4% | $8.00 | — | 10 |
| SK.PA | SEB | $48.96 +0.78% | 50% | €73.45 | 11x | 11 |
| ACAD | Acadia Pharmaceuticals | $21.10 -1.03% | 50% | $31.65 | 9.6x | 20 |
| INRN.SW | Interroll Holding | $1,604.00 +3.48% | 49.6% | $2,400.00 | 23.9x | 7 |
| SF.ST | Stillfront Group | $5.16 -2.46% | 49.6% | $7.71 | — | 4 |
| DAVE | Dave Inc | $228.46 -5.16% | 49.4% | $341.38 | 14.7x | 8 |
| QDT.PA | Quadient | $12.34 +3.01% | 49.4% | €18.43 | — | 6 |
| FSLY | Fastly | $16.32 -0.49% | 48.6% | $24.25 | — | 8 |
| WEW.DE | Westwing | $14.70 +3.89% | 48.5% | €21.83 | 133.6x | 3 |
| NEM.DE | Nemetschek | $63.35 -1.25% | 48.4% | €94.02 | 31.5x | 15 |
| ELF | elf Beauty | $52.90 -0.41% | 47.6% | $78.07 | 120.2x | 15 |
| KRUS | Kura Sushi USA | $54.28 -0.09% | 47.2% | $79.90 | — | 10 |
| BABA | Alibaba | $130.00 -1.12% | 47.1% | $191.29 | 20.1x | 40 |
| EUZ.DE | Eckert and Ziegler | $15.02 -0.99% | 47.1% | €22.10 | 19x | 3 |
| NCNO | nCino | $16.07 +1.52% | 47.1% | $23.64 | 321.4x | 14 |
| XPER | Xperi | $7.75 +2.65% | 47.1% | $11.40 | — | 5 |
| BROS | Dutch Bros | $52.12 -2.51% | 46.9% | $76.58 | 81.4x | 24 |
| SHOP | Shopify | $103.00 -1.77% | 46.7% | $151.11 | 101x | 45 |
| TOST | Toast | $23.16 +0.52% | 46.6% | $33.96 | 34.6x | 25 |
| ONTEX.BR | Ontex Group | $2.66 -3.27% | 46.6% | €3.90 | 13.3x | 6 |
| FVRR | Fiverr | $11.09 +2.31% | 46.5% | $16.25 | 14.4x | 8 |
| NVCR | NovoCure | $17.96 +0.34% | 46.4% | $26.29 | — | 7 |
| AGIO | Agios Pharmaceuticals | $28.14 -2.26% | 46.1% | $41.12 | — | 8 |
| SAP | SAP | $175.95 -0.19% | 45.8% | $256.50 | 24.3x | 12 |
| CRM | Salesforce | $180.07 +2.13% | 45.7% | $262.27 | 23.1x | 53 |
| UBER | Uber | $71.82 -2.43% | 45.4% | $104.45 | 17.8x | 50 |
| HYPR | Hyperfine | $1.49 -0.67% | 45.4% | $2.17 | — | 3 |
| RKT | Rocket Companies | $13.79 -0.58% | 45.4% | $20.05 | — | 14 |
| CERT | Certara | $5.24 +1.35% | 45.4% | $7.62 | — | 11 |
| TMCI | Treace Medical Concepts | $2.78 -2.11% | 43.9% | $4.00 | — | 3 |
| TMV.DE | TeamViewer | $5.71 +2.24% | 43.8% | €8.21 | 7.8x | 15 |
| ASAN | Asana | $6.62 +4.09% | 43.8% | $9.52 | — | 13 |
| TIP.MI | Tamburi Investment Partners | $8.64 +0.47% | 43.5% | €12.40 | 25.4x | 4 |
| SKYW | SkyWest Airlines | $84.82 +0.08% | 43.2% | $121.50 | 8.1x | 6 |
| BRZE | Braze | $24.35 +4.02% | 43.1% | $34.85 | — | 20 |
| G24.DE | Scout24 | $72.25 +2.92% | 42.7% | €103.12 | 20x | 16 |
| VTOL | Bristow Group | $42.73 -0.63% | 42% | $60.67 | 11.1x | 3 |
| ANAB | AnaptysBio | $59.71 -1.16% | 41.4% | $84.45 | — | 11 |
| MMSI | Merit Medical Systems | $64.17 +0.85% | 41.2% | $90.64 | 27.7x | 11 |
| REY.MI | Reply SpA | $104.90 +0.96% | 41.1% | €148.00 | 14.8x | 12 |
| UPST | Upstart Holdings | $28.56 -1.01% | 40.8% | $40.20 | 69.7x | 15 |
| FOUR | Shift4 Payments | $43.24 -0.67% | 40.6% | $60.81 | 49.7x | 21 |
| GRND | Grindr | $12.95 +0.94% | 40.5% | $18.20 | 28.2x | 5 |
Analysis and Context
This screener currently shows 137 stocks meeting our value criteria — updated daily with live market data from 570+ tracked securities. The average P/E ratio of filtered stocks is 41.7x, compared to the historical S&P 500 median of 24.7x. The most represented sector is Healthcare with 52 companies. Value investing isn't simply about buying cheap stocks — it means identifying companies trading below intrinsic value before the market recognizes it. Low valuations can signal genuine mispricing, but may also reflect structural issues, cyclical weakness, or deserved discounts for deteriorating fundamentals. The average analyst price target upside for this list is 82%. Always combine these quantitative screens with qualitative analysis of competitive moats, management quality, and balance sheet strength before investing.
Ready to invest?
Compare the best brokers for US and European stocks — fees, platforms and account types side by side.
Compare brokers →